|Bid||255.00 x 800|
|Ask||254.98 x 900|
|Day's Range||254.53 - 258.95|
|52 Week Range||208.07 - 287.94|
|Beta (3Y Monthly)||0.68|
|PE Ratio (TTM)||19.19|
|Earnings Date||Oct 14, 2019 - Oct 18, 2019|
|Forward Dividend & Yield||4.32 (1.68%)|
|1y Target Est||296.14|
Markets closed lower on Friday after a report stated that Fed officials would reduce the benchmark interest rates in its next meeting by only a quarter percentage points.
The Energy and Commerce Committee in the U.S. House of Representatives advanced several health care initiatives Wednesday, the most significant of which could curb surprise medical bills.
Earnings season is underway and corporate buybacks are set to boost earnings per share for S&P 500 companies.
UnitedHealth raised profit expectations for the year after second-quarter earnings climbed almost 13%, and the nation's largest health insurer continued expanding beyond its core business and into care delivery. A nearly 12% jump in revenue from the company's pharmacy benefit management operation helped UnitedHealth beat Wall Street expectations for the recently completed quarter. UnitedHealth's OptumRx business added more customers and moved deeper into specialty services like the infusion of drugs at patient homes.
UnitedHealth, Honeywell, Wayfair, AT&T, Microsoft and Impossible Foods are the companies to watch.
U.S. stock indexes edged lower on Thursday as investors awaited more developments around trade, while Netflix posted a surprise drop in U.S. subscribers, kicking off earnings for the FAANG group of stocks on a sour note. Losses in Netflix also dragged the communication services sector, one of the best-performing S&P sectors so far this year, 1.20% lower. "Netflix did nothing to soothe investor concerns around what earnings prospects are likely to unfold over the next couple of weeks," said Mark Luschini, chief investment strategist at Janney Montgomery Scott in Philadelphia.
"You can expect us not to change our stance on rebates," Chief Executive Officer David Wichmann said on a conference call with analysts to discuss the earnings. UnitedHealth shares were down $5.65, or 2%, at $260.94 (£209.27) in morning trading, after earlier rising about 1% in premarket trading on news the company beat estimates for quarterly profit and boosted its forecast for 2019 earnings. "We think UnitedHealth is underperforming the peers today likely because on the call, they guided 2019 revenues to now be 'at or slightly below' the prior revenue guidance range of $243-245 billion," Scott Fidel an analyst at Stephens said.